Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 41,750
-2,000 (-4.57%)
At close: Nov 12, 2026
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 310.45 billion as of November 12, 2026. It is the 19,720th most valuable company in the world and the 607th biggest in South Korea.
Market Cap
310.45B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#607 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 310.45B, an increase of 38.25%. That is a compound annual growth rate of 39.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 310.45B | -20.48% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InBody Co.,Ltd | 544.54B |
| BioNote | 459.66B |
| i-SENS | 386.49B |
| T&L Co., Ltd. | 379.19B |
| WON TECH | 317.63B |
| ToolGen | 298.54B |
| Curexo | 278.50B |
| Value Added Technology | 245.10B |